I am honored to present The State of the Medtech Industry keynote address on October 18th at the MPO Summit in San Diego. I’ll cover the forces changing product lines and potentially introducing new competitors into the medtech supply chain.
Tony Freeman
I’m pleased to announce A. S. Freeman Advisors’ annual Global Trends in Medtech 2023 is available here for download and distribution. Key points in this year’s presentation include: Medtech market size and growth rate Demographic and economic trends reshaping OEM product lines for the next decades Redefinition of what constitutes a medical device The size and growth rate of the medical device supply chain Changing roles for the contract manufacturing incumbents? Strategies for participating in the digitization of devices and systems As always, I am happy to present Global Trends to you or your firm. Please reach me at tfreeman@asfreeman.com with questions, comments, or requests. Best regards, Tony Freeman
Atalys has acquired precision moldmaker ROMOLD, Inc. of Rochester, New York. A.S. Freeman Advisors, LLC advised ROMOLD on this transaction. For more information please contact Tony Freeman. Anthony S. Freeman A.S. Freeman Advisors, LLC (917) 868-0772 tfreeman@asfreeman.com asfreeman.com
Tony Freeman will be attending MPO Summit 2022 and Device Talks West 2022, and welcomes the opportunity to meet with colleagues. Schedule: MPO Summit in Austin, TX on Tuesday, October 18 – at Austin Marriot Downtown Device Talks West in Santa Clara on WednesdayOctober 19 – at Santa Clara Convention Center Get in touch with me at (917) 878-0772 or by email at tfreeman@asfreeman.com to set up a time to get together.
My latest piece for MPO Magazine discusses business strategies for the medical device supply chain in response to two trends: the rise of reliance on contract manufacturers vs OEMs, and supply chain consolidation.
Two strategies have emerged: the integrated contract manufacturer approach, and the specialist niche approach. I discuss the advantages and disadvantages of each, and opportunities for strategic expansion.
My annual report on Global Trends in Medtech for 2022 is now available.
I presented Part 1 and Part 2 for MPO at their webinar series on March 1 & 2, 2022, followed by a panel discussion on March 3. MPO will archive the webinar segments for one year (free registration may be required).
I am presenting at MPO’s “Global Trends in Medtech 2022: OEMs and the Supply Chain” webinar series on March 1, 2 & 3, 2022. Registration is free for this informative three-part series. SESSION 1: TUESDAY, MARCH 1 – 2:00 p.m. The OEM Landscape—Fundamental Change on the Horizon The OEM Landscape and Business Drivers How Big Is the Market? What’s the Growth Rate? The Impact of COVID and Lessons Learned A Slowly but Clearly Changing Business Model for OEM Are Limits on Medical Spending Starting to Appear? Four Most Significant Product Trends SESSION 2: WEDNESDAY, MARCH 2 – 2:00 p.m. OEM Product Trends Will Reshape the Supply Chain—Dethroning Current Kings Changing OEM Strategy Triggering a New Supply Chain Structure How Big Is the Supply Chain? What’s the Growth Rate? Myths Believed by Traditional Supply Chain Companies COVID, Automation, and LCCs Will Manufacturers of Non-Digital Products Survive? Which Supply Chain Companies Are Best Positioned to Prosper? SESSION 3: THURSDAY, MARCH 3 – 2:00 p.m. Panel Discussion of Medtech’s Global Trends The final portion of this three-part series will feature a panel of industry representatives discussing topics and points made during the first two sessions. Moderated by Tony Freeman, this candid conversation will look at factors impacting OEMs as well as the supply chain. The audience will be encouraged to pose questions to the panel as they look ahead as to what they expect in 2022 and beyond. REGISTER NOW AT MPO
Dear Colleague, I am pleased to announce the acquisition of Berg Manufacturing by Biomerics NLE. The Berg transaction notably extends Biomerics’ micromachining capabilities. A.S. Freeman Advisors advised Biomerics on the transaction. You can read the entire press release here. For more information on the medical device supply chain M&A market, please contact me at tfreeman@asfreeman.com or (917) 868-0772. Best regards, Tony Freeman